Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01939379

Adductor Canal Nerve Block Following Total Knee Arthroplasty

Adductor Canal Nerve Block Following Total Knee Arthroplasty: A Randomized, Prospective Study Comparing High vs. Low Volume Bolus of 0.33% Ropivacaine

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Loma Linda University · Academic / Other
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is that an adductor canal nerve block (putting numbing medicine near the nerve) has been shown to produce excellent pain relief with less pain medication use after knee replacement surgery.The investigators will be comparing the amount of pain relief following knee replacement surgery when you have a nerve block in place. There will be approximately 66 subjects participating in this study. After surgery subjects will receive numbing medication every 6 hours for 48 hours. Subjects will also receive a morphine PCA (patient controlled analgesia) after surgery and pain medication by mouth every 4 hours around the clock with the option to receive more pain medication if needed. Subjects will participate in the study up to 3 days.

Conditions

Interventions

TypeNameDescription
DRUGMorphine PCA started at the end of surgery, 1 Percocet 1/325mg every 4 hours; may receive a second Percocet if needed.
DRUGFor the 30ml ropivacaine the intervention would be the subject can request extra pain medication which would be Percocet and/or morphine PCA.

Timeline

Start date
2013-09-01
Primary completion
2017-07-25
Completion
2017-07-25
First posted
2013-09-11
Last updated
2021-04-20

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01939379. Inclusion in this directory is not an endorsement.